Detection of Autoantibodies to Citrullinated BiP in Rheumatoid Arthritis Patients and Pro-inflammatory Role of Citrullinated BiP in Collagen-induced Arthritis

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2011 Nov 24

PMID 22108001

Citations 35

Authors

Hirofumi Shoda

Keishi Fujio

Mihoko Shibuya

Tomohisa Okamura

Shuji Sumitomo

Akiko Okamoto

Tetsuji Sawada

Kazuhiko Yamamoto

Affiliations

Soon will be listed here.

Abstract

Introduction: Anti-citrullinated protein/peptide antibodies (ACPAs) are highly specific to rheumatoid arthritis (RA) patients and are thought to have a close relationship with the pathogenesis of arthritis. Several proteins, including fibrinogen, vimentin, and alpha-enolase, were reported as ACPA-target antigens, and their importance in RA pathogenesis was widely proposed. We identified citrullinated immunoglobulin binding protein (citBiP) as another ACPA target in RA patients and examined its pro-inflammatory role in arthritis.

Methods: We measured the levels of anti-citBiP, anti-BiP, and anti-cyclic citrullinated peptide (CCP) antibodies in the serum of RA patients (n = 100), systemic lupus erythematosus (SLE) patients (n = 60), and healthy controls (n = 30) using ELISA and immunoblotting. Epitope mapping was performed using 27 citBiP-derived peptides. In the mouse study, after DBA/1J mice were immunized with BiP or citBiP, serum titers of ACPAs were measured by ELISA and immunohistochemistry. The development of collagen-induced arthritis (CIA) was observed in BiP- or citBiP-pre-immunized mice.

Results: The serum levels of anti-BiP and anti-citBiP antibodies were significantly increased in RA patients, although only anti-BiP antibodies were slightly increased in SLE patients. Interestingly, anti-citBiP antibody levels were higher than anti-BiP antibody levels in 72% of RA patients, whereas no significant increase in anti-citBiP antibody levels was detected in SLE patients and healthy controls. The serum levels of anti-CCP antibodies were correlated with those of anti-citBiP antibodies in RA patients (R2 = 0.41). Several citrulline residues of citBiP were determined to be major epitopes of anti-citBiP antibodies, one of which showed cross-reactivity with CCP. Immunization of DBA/1J mice with citBiP induced several kinds of ACPAs, including anti-CCP and anti-citrullinated fibrinogen antibodies. Pre-immunization with citBiP exacerbated CIA, and anti-CCP antibody levels were increased in citBiP-pre-immunized CIA mice.

Conclusions: CitBiP is a newly described ACPA target that may play a pro-inflammatory role in arthritis.

Citing Articles

The Differential Expressions and Associations of Intracellular and Extracellular GRP78/Bip with Disease Activity and Progression in Rheumatoid Arthritis.

Liu G, Wu J, Wang Y, Xu Y, Xu C, Fang G Bioengineering (Basel). 2025; 12(1).

PMID: 39851332 PMC: 11761566. DOI: 10.3390/bioengineering12010058.

Metabolomics Reveals Disturbed Amino Acid Metabolism During Different Stages of RA in Collagen-Induced Arthritis Mice.

Zhang X, Yin M, Zhang D, Cao D, Hou X, Xu Z Inflammation. 2024; 47(5):1853-1867.

PMID: 39212888 DOI: 10.1007/s10753-024-02123-1.

Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis.

Yang M, Zhu L Int J Mol Sci. 2024; 25(5).

PMID: 38473934 PMC: 10931770. DOI: 10.3390/ijms25052688.

CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets.

Callebaut A, Guyer P, Derua R, Buitinga M, Manganaro A, Yi X Diabetes. 2024; 73(5):728-742.

PMID: 38387030 PMC: 11043062. DOI: 10.2337/db23-0588.

Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung Disease.

Nava-Quiroz K, Lopez-Flores L, Perez-Rubio G, Rojas-Serrano J, Falfan-Valencia R Cells. 2023; 12(24).

PMID: 38132149 PMC: 10741699. DOI: 10.3390/cells12242829.

References

Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K . Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med. 1999; 5(7):760-7. DOI: 10.1038/10480. View

Girbal-Neuhauser E, Durieux J, Arnaud M, Dalbon P, Sebbag M, Vincent C . The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. 1999; 162(1):585-94. View

Senshu T, Akiyama K, Kan S, ASAGA H, Ishigami A, Manabe M . Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues. J Invest Dermatol. 1995; 105(2):163-9. DOI: 10.1111/1523-1747.ep12317070. View

Ireland J, Herzog J, Unanue E . Cutting edge: unique T cells that recognize citrullinated peptides are a feature of protein immunization. J Immunol. 2006; 177(3):1421-5. DOI: 10.4049/jimmunol.177.3.1421. View

Kuhn K, Kulik L, Tomooka B, Braschler K, Arend W, Robinson W . Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest. 2006; 116(4):961-73. PMC: 1421345. DOI: 10.1172/JCI25422. View

Shlomchik M, Craft J, Mamula M . From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol. 2002; 1(2):147-53. DOI: 10.1038/35100573. View

Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. DOI: 10.1002/art.1780400928. View

Vossenaar E, Nijenhuis S, Helsen M, van der Heijden A, Senshu T, van den Berg W . Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 2003; 48(9):2489-500. DOI: 10.1002/art.11229. View

Corrigall V, Bodman-Smith M, Brunst M, Cornell H, Panayi G . Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis. Arthritis Rheum. 2004; 50(4):1164-71. DOI: 10.1002/art.20134. View

10.

Gyorgy B, Toth E, Tarcsa E, Falus A, Buzas E . Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol. 2006; 38(10):1662-77. DOI: 10.1016/j.biocel.2006.03.008. View

11.

Lipsky P, van der Heijde D, St Clair E, Furst D, Breedveld F, Kalden J . Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000; 343(22):1594-602. DOI: 10.1056/NEJM200011303432202. View

12.

Deng G, Zheng L, Chan F, Lenardo M . Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat Med. 2005; 11(10):1066-72. DOI: 10.1038/nm1304. View

13.

Bodman-Smith M, Corrigall V, Kemeny D, Panayi G . BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals. Rheumatology (Oxford). 2003; 42(5):637-44. DOI: 10.1093/rheumatology/keg204. View

14.

van Gaalen F, Linn-Rasker S, van Venrooij W, de Jong B, Breedveld F, Verweij C . Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 2004; 50(3):709-15. DOI: 10.1002/art.20044. View

15.

Zechel M, Krawetz M, Singh B . Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice. Immunol Rev. 1998; 164:111-8. DOI: 10.1111/j.1600-065x.1998.tb01213.x. View

16.

Zhao X, Okeke N, Sharpe O, Batliwalla F, Lee A, Ho P . Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther. 2008; 10(4):R94. PMC: 2575608. DOI: 10.1186/ar2478. View

17.

Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M . Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet. 2003; 34(4):395-402. DOI: 10.1038/ng1206. View

18.

Hueber W, Utz P, Robinson W . Autoantibodies in early arthritis: advances in diagnosis and prognostication. Clin Exp Rheumatol. 2004; 21(5 Suppl 31):S59-64. View

19.

Courtenay J, Dallman M, Dayan A, Martin A, Mosedale B . Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980; 283(5748):666-8. DOI: 10.1038/283666a0. View

20.

Rantapaa-Dahlqvist S, de Jong B, Berglin E, Hallmans G, Wadell G, Stenlund H . Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003; 48(10):2741-9. DOI: 10.1002/art.11223. View